- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06274723
Responses to E-cigarette Message Source and Presentation
February 20, 2024 updated by: Donghee Nicole Lee, University of Massachusetts, Worcester
Identifying and Examining the Effects of Source and Presentation on Responses to Electronic Cigarette Public Education Messages in Young Adult Vapers and Non-vapers - Part 1
The goal of this clinical trial is to use crowdsourcing to test the effects of a message source (expert and peer) and message presentation types (one-sided and two-sided) to identify the optimal message type for young adults who vape and do not vape.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
800
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- US residents ages 18-24
- Fluent in English
- Reporting either vaping in the past 30 days or not having vaped in the past 30 days but susceptible to vaping
Exclusion Criteria:
- Age less than 18 or above 24
- Not fluent in English
- Not a member of partnering crowdsourcing behavioral research platform conducting the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Source
Participants in source arm will receive e-cigarette education messages manipulated in one of two source types.
|
Participants will view a brief description of an expert source.
Participants will view a brief description of a peer source.
|
Experimental: Sidedness
Participants in sidedness arm will receive e-cigarette education messages manipulated in one of two sidedness types.
|
Participants will view e-cigarette education messages in two-sided.
Participants will view e-cigarette education messages in one-sided.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Message acceptance
Time Frame: 20 minutes
|
Message acceptance will be measured by five-item perceived message effectiveness questionnaire, such as the extent to which the message was worth remembering, grabbed their attention, powerful, convincing, and meaningful on a scale from 1 (Strongly disagree) to 5 (Strongly agree).
|
20 minutes
|
Harm perceptions
Time Frame: 20 minutes
|
Harm perceptions will be measured by four-item e-cigarette harm perceptions questionnaire, such as the extent to which vaping is safe, contain flavors that are safe to use, contain dangerous chemicals, and harmful to health on a scale from 1 (Strongly disagree) to 5 (Strongly agree).
|
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Psychological reactance
Time Frame: 20 minutes
|
Psychological reactance will be measured by six-item reactance questionnaire, such as perceptions of messages being manipulative, misleading, distorted, overblown, exaggerated, and overstated on a scale from 1 (Strongly disagree) to 5 (Strongly agree), and a four-item anger scale, measuring the extent to which the messages made participants feel irritated, angry, annoyed, and aggravated on a scale from 1 (not at all) to 5 (very much).
|
20 minutes
|
Message liking
Time Frame: 20 minutes
|
Message liking will be measured by a single-item liking of the message on scale from 1 (Dislike very much) to 5 (Like very much).
|
20 minutes
|
Source trust
Time Frame: 20 minutes
|
Source trust will be measured by a single-item trust in health information source questionnaire, such as trust in source about vaping information on a scale from 1(Not at all) to 5 (Very much so).
|
20 minutes
|
Attitudes
Time Frame: 20 minutes
|
Attitudes will be measured by seven-item vaping attitudes questionnaire, such as vaping is unenjoyable/enjoyable, unhealthy/healthy, dangerous/safe, boring/fun, stupid/smart, not cool/cool, and not attractive/attractive on a five-point bipolar scale.
|
20 minutes
|
Behavioral intentions to vape or try vaping
Time Frame: 20 minutes
|
Behavioral intentions to vape will be measured by a three-item behavioral intentions questionnaire, such as intentions to vape (for vapers)/try vaping (for non-vapers) soon, anytime during the next year, would use offered by one of their best friends on a scale from 1 (Definitely not) to 5 (Definitely yes).
|
20 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 1, 2024
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
January 17, 2024
First Submitted That Met QC Criteria
February 20, 2024
First Posted (Actual)
February 23, 2024
Study Record Updates
Last Update Posted (Actual)
February 23, 2024
Last Update Submitted That Met QC Criteria
February 20, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00001220
- 1K99CA281094-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaping
-
Philip Morris Products S.A.CompletedNicotine | Nicotine Vaping | VapingUnited Kingdom
-
St. Jude Children's Research HospitalRecruitingVaping | Vaping CessationUnited States
-
University of RochesterNational Cancer Institute (NCI)Completed
-
UNC Lineberger Comprehensive Cancer CenterNational Institute on Drug Abuse (NIDA); Food and Drug Administration (FDA)Recruiting
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA)Recruiting
-
Philip Morris Products S.A.CompletedNicotine | Nicotine Vaping | VapingUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Food and...Completed
-
Mayo ClinicWithdrawn
-
Clemson UniversityUniversity of VermontCompleted
Clinical Trials on Expert
-
University College CorkCompleted
-
University of ValladolidSanidad de Castilla y LeónActive, not recruiting
-
University of California, San FranciscoUniversity of CaliforniaCompleted
-
University Medicine GreifswaldUnknownTobacco Smoking
-
SiVIEWNot yet recruitingEye Diseases | AmetropiaFrance
-
Lahey ClinicTerminatedLumbar Spinal Stenosis | Lumbar Spondylolisthesis | Degenerative Spondylolisthesis | Grade 1 SpondylolisthesisUnited States, Canada
-
Wuerzburg University HospitalHannover Medical School; Goethe University; University Hospital Tuebingen; Universitätsklinikum... and other collaboratorsCompletedRare Diseases | Orphan DiseasesGermany
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Catalan Institute of HealthUnknown
-
St. Olavs HospitalNorwegian Labour and Welfare AdministrationRecruitingMusculoskeletal Diseases | Mental DisorderNorway
-
Indiana UniversityNational Institute on Aging (NIA); Regenstrief Institute, Inc.RecruitingAlzheimer Disease | Caregiver BurdenUnited States